Survival of patients with metastatic breast cancer: twenty-year data from two SEER registries

BMC Cancer

Table 4 Cancer sites with survival times demonstrated to follow the lognormal distribution in the literature as at year 2004

Cancer sites	Author
Head and neck cancer	Berg [25], Mould[7]
Nasal sinus cancer	Berg [25]
Mouth and throat cancer	Boag [3]
Mouth	Berg [25]
Thyroid	Tai*[26]
Larynx, tongue	Mould & Tai*[27]
Non small cell lung cancer	Berg [25]
Small cell lung cancer	Tai*[10]
Intraocular melanoma	Gamel [8]
Cutaneous melanoma	Gamel [9]
Breast cancer	Boag [3], Berg [25], Rutqvist [5,15], Gamel [28,29], Haybittle [30], Royston [31], Tai*[12]
Bone sarcomas	Berg [25]
Cancer of uterine cerivx	Mould & Boag*[6], Berg [25]
Ovarian cancer	Berg [25], Tai*[32], Royston [31]
Hypernephroma	Berg [25]
Bladder cancer	Berg [25]
Prostate Cancer	Mould & Tai*[33]
Gastric cancer	Berg [25], Maetani [34]
Lymphoma	Berg [25]
Chronic leukemia	Tivey [35]
Brain tumors	Berg [25]
42 SEER cancer sites	Tai [36]

SEER, Surveillance, Epidemiology, and End Results;
*, phase 2 validation also performed, i.e. concordance between Kaplan-Meier method and lognormal model.

ISSN: 1471-2407